The use of disposable medical sensors is continuously increasing, fueling a multibillion-dollar global industry. BCC Research predicts that this market will expand at a healthy double-digit growth rate worldwide, with the potential to reach $9 billion by 2022. An increase in geriatric populations all over the world will lead to more demand for continuous health monitoring devices for a larger number of diseases pertaining to cardiovascular, audiology and urology systems.
Biologic imaging reagents play a fundamental role in today’s medical, pharmaceutical and biotechnology industries. Such reagents are integral to the diagnostics industry, which is the largest market for these products. Driven primarily by advancements in biomarker technology in medical diagnostics, the global market for biologic imaging reagents has the potential to reach $23.9 billion by 2022. In a new study by BCC Research, the industry’s prospects are examined by the main reagent classes: contrast, nuclear (radioactive) and optical.
Liquid biopsy is rapidly gaining traction as a supplement or alternative to tissue biopsy. Earlier this year, we noted that liquid biopsies continue to draw investments, and efforts prevail to establish the technique in mainstream medicine. Liquid biopsies have been likened to a Holy Grail of cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumors, which can be expensive for the healthcare system as well as painful for patients. For diagnosis of cancer, liquid biopsies could spare some of the risky tissue biopsies and reduce reliance on computed tomography scans, which must be limited because of the danger posed by overexposure to radiation.
The steadily increasing demand for substance abuse test equipment forms a building block for medical technology companies, according to a new study by BCC Research. From estimated sales of $3 billion in 2016, the global drug testing industry is predicted to reach almost $4 billion by 2022. Technological advances and the entry of new innovative companies in the diagnostics industry have transformed the market.